NCT04332653 2026-03-09NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsNeoImmuneTechPhase 1/2 Completed215 enrolled 30 charts
NCT02834052 2024-06-07Pembrolizumab + Poly-ICLC in MRP Colon CancerAugusta UniversityPhase 1/2 Completed42 enrolled 13 charts
NCT02735239 2024-03-22Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal CancerLudwig Institute for Cancer ResearchPhase 1/2 Completed73 enrolled 18 charts
NCT03361228 2020-05-21A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled 4 charts